These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of total hyphema with relatively low-dose tissue plasminogen activator. Kim MH; Koo TH; Sah WJ; Chung SM Ophthalmic Surg Lasers; 1998 Sep; 29(9):762-6. PubMed ID: 9760614 [TBL] [Abstract][Full Text] [Related]
4. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification. Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778 [TBL] [Abstract][Full Text] [Related]
5. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery. Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630 [TBL] [Abstract][Full Text] [Related]
10. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery. Wedrich A; Menapace R; Mühlbauer-Ries E Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808 [TBL] [Abstract][Full Text] [Related]
11. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract. Ren Y; Du S; Zheng D; Shi Y; Pan L; Yan H BMC Ophthalmol; 2021 Jun; 21(1):245. PubMed ID: 34088282 [TBL] [Abstract][Full Text] [Related]
12. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. Wedrich A; Menapace R; Ries E; Polzer I J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671 [TBL] [Abstract][Full Text] [Related]
13. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021 [TBL] [Abstract][Full Text] [Related]
14. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants. Zalta AH; Sweeney CP; Zalta AK; Kaufman AH Arch Ophthalmol; 2002 Nov; 120(11):1487-93. PubMed ID: 12427061 [TBL] [Abstract][Full Text] [Related]
15. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629 [TBL] [Abstract][Full Text] [Related]
17. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery. Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453 [TBL] [Abstract][Full Text] [Related]
18. Intraocular surgery under adalimumab therapy in patients with refractory uveitis: a single center study of 23 eyes. Kunimi K; Usui Y; Tsubota K; Kezuka T; Goto H Jpn J Ophthalmol; 2021 Nov; 65(6):836-842. PubMed ID: 34491475 [TBL] [Abstract][Full Text] [Related]
19. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience. Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581 [TBL] [Abstract][Full Text] [Related]
20. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis]. Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]